LFG
MRNA icon

Larson Financial Group’s Moderna MRNA Stock Holding History

Larson Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$2K – 1143
2021
Q3 		$2K Buy
+200
New +$73.8K ﹤0.01% 789

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Larson Financial Group's MRNA Position: Q1 2026 in Review

Larson Financial Group increased its Moderna (MRNA) stake by 18% in Q1 2026, buying an estimated $15.7K and bringing the position to 2,166 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Larson Financial Group first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Larson Financial Group held 2,166 shares of Moderna worth $110K as of Q1 2026.
  • Larson Financial Group bought 336 Moderna shares in Q1 2026, an estimated $15.7K.
  • Moderna made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #949 holding.
  • Larson Financial Group first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.